BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220204T090000
DTEND;TZID=Europe/Stockholm:20220204T093000
DTSTAMP:20260406T185347
CREATED:20220117T164155Z
LAST-MODIFIED:20220117T171054Z
UID:10000508-1643965200-1643967000@www.scilifelab.se
SUMMARY:IMPRESS-Norway and implementing precision cancer medicine in Norway
DESCRIPTION:On February 4\, oncologist\, and Head of Research at Division of Cancer Medicine at Oslo University Hospital Professor Åslaug Helland will give a talk about her mission with the clinical precision medicine study IMPRESS-Norway that she co-founded in 2021. She is also a Professor at the University of Oslo. Åslaug is the PI of the IMPRESS-N study with the goal of “Improving public cancer care by implementing precision medicine in Norway\,” and it is a national clinical study for patients with advanced cancer after standard therapy\, with multiple Norwegian healthcare partners as well as industry collaborators. The effort is preparing Norway towards the many sustainable future benefits precision medicine has to offer for future healthcare solutions (Read more). \n\n\n\nregister to receive zoom link\n\n\n\nBiography \n\n\n\n\n\n\n\nÅslaug Helland\, MD\, PhD\, is a Group leader at the Institute for Cancer Research\, Norwegian Radium Hospital (NRH)\, Oslo\, Norway\, and Senior oncologist\, Dept of Oncology\, Oslo University Hospital\, Radiumhospital. She is also Professor at the University of Oslo Institute of Clinical Medicine. Åslaug obtained her MD degree in 1995\, and later her PhD in Medicine in 2000\, from the University of Oslo. She pursued her postdoctoral studies during 2003/2004 at Stanford University\, and in 2007/2008 as a visiting scientist at the Peter MacCallum Cancer Centre in Melbourne Australia\, adding to her international experience. Åslaugs research group focuses on translational studies on solid tumours\, with a special interest in pancreatic cancers\, lung cancers\, ovary cancers and colorectal cancers. They perform whole genome analyses on patient material\, aiming at identifying predictive and prognostic biomarkers as well as more targeted analyses for the identification of pathways and immune mechanisms of interest. By increasing the understanding of the underlying biology of tumour development\, they aim at improving cancer patient care. She furthermore led several clinical and translational studies in lung cancer. \n\n\n\nÅslaug is the PI of the IMPRESS-Norway study with the goal of “Improving public cancer care by implementing precision medicine in Norway\,” and it is a national clinical study for patients with advanced cancer after standard therapy. During 2019\, Oslo Cancer Cluster hosted a series of workshops with public and private stakeholders in cancer with the goal to accelerate the implementation of cancer precision medicine in Norway. The initial idea for IMPRESS emerged in one of these workshops. A dedicated team at Oslo University Hospital quickly turned it into a national effort together with colleagues at university hospitals across Norway. \n\n\n\nIMPRESS involves the active support of leading global pharmaceutical companies that will provide the study drugs and contribute with per patient fees. Public funding will help to ensure this innovative study paves the way for more cancer clinical trials in Norway. National infrastructure for precision diagnostics is needed and is currently being set up at all Norwegian cancer hospitals. Cancer patients who are eligible for clinical trials can soon be tested and selected based on their specific genetic profile. \n\n\n\n\n\n\n\n\n“Clinical Talks” has been renewed for yet another exciting\, innovative\, and enlightening season. This season will focus on sustainable innovations within Life Sciences\, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations . \n\n\n\nSeason 5\, will be held September 2021 until March 2022 with scheduled Talks\, during Friday mornings 09-09:30 am via ZOOM (with some time-zone friendly adjustments for our international speakers). Each session consists of a talk given by our invited speaker followed by Q&A. The seminar is an open educational seminar series for our ever-expanding Life Science community.
URL:https://www.scilifelab.se/event/impress-norway-and-implementing-precision-cancer-medicine-in-norway/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220211T140000
DTEND;TZID=Europe/Stockholm:20220211T160000
DTSTAMP:20260406T185347
CREATED:20220121T155806Z
LAST-MODIFIED:20220121T155807Z
UID:10000511-1644588000-1644595200@www.scilifelab.se
SUMMARY:BioImage Analysis support - Call4Help
DESCRIPTION:Every 1st week of the month (mainly on Tuesdays\, but there might be exceptions) the BioImage Informatics Facility together with microscopy expert Sylvie Le Guyader (LCI\, Karolinska Institutet) organizes a Call4Help session. The aim is to offer combined expertise towards microscopy and bioimage analysis. All researchers from Swedish institutes can participate. \n\n\n\nThe ideal timepoint to join the Call4Help session is when a researcher has performed pilot experiments and has tried out first analysis approaches – but before having recorded hundreds of images. Combining BIIF’s expertise in BioImage Analysis with microscopy expertise we can discuss ways to record the images that allow analysis afterwards. We will discuss different analysis approaches using mainly open-source software (Fiji\, CellProfiler\, QuPath\, Ilastik\, KNIME)\, but also commercial systems\, if needed (Imaris). \n\n\n\nThe Call4Help session format has been introduced to the BioImage Analysis community by NEUBIAS and ScopeM. \n\n\n\nHow to participate? \n\n\n\nWe prefer if you prepare a short presentation and upload it together with some example images according to the steps 1 and 2 below. This makes it easier for us when we have to prioritize between projects and allows us to prepare for the meeting. But if time permits\, we can also accept participants without this info. \n\n\n\nStep1: \n\n\n\nPrepare a short presentation (5-7 min)  – use the following template for your presentation: \n\n\n\nhttp://bit.ly/BIIF_C4H_slideTemplate \n\n\n\nSlide template by NEUBIAS/ScopeM \n\n\n\nStep2: \n\n\n\na) Upload your presentation \n\n\n\nUpload your presentation to a drive of your choice. You can also use our Call4Help google drive. Note that files shared on our Call4Help drive will be available to everyone until the session is over. \n\n\n\nhttp://bit.ly/BIIF_C4H_Drive \n\n\n\nb) Upload example images for testing. \n\n\n\nUpload example images for testing either to the drive of your choice or our Call4Help google drive above. \n\n\n\nhttp://bit.ly/BIIF_C4H_Drive \n\n\n\nc) Register by filling out the registration form: \n\n\n\nhttp://bit.ly/BIIF_C4H_Registration \n\n\n\nStep 3: \n\n\n\nJoin the zoom-session. \n\n\n\nIf your problem is selected for presentation\, you will get a time-slot of 30 – 60 minutes within the session. \n\n\n\nWhat are the Deadlines \n\n\n\nSubmission of a problem and upload of example data: Friday the week before the session. \n\n\n\nNotification about participation: The day before the session. \n\n\n\nNext Call4Help session \n\n\n\nFriday\, February 11\, 2022\, 14:00-16:00. Deadline for application: Tuesday\, February 8\, 2022.
URL:https://www.scilifelab.se/event/bioimage-analysis-support-call4help/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="Bioimage Informatics Unit":MAILTO:biif@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220218T090000
DTEND;TZID=Europe/Stockholm:20220218T093000
DTSTAMP:20260406T185347
CREATED:20220117T165253Z
LAST-MODIFIED:20220117T171034Z
UID:10000509-1645174800-1645176600@www.scilifelab.se
SUMMARY:Spearheading the cardiovascular precision medicine with innovative medical tools
DESCRIPTION:On February 18\, we have invited Dr. Tero-Pekka Alastalo\, to give a talk about his experience with co-founding the precision medicine company Blueprint Genetics in 2012. What started out as a technology development spinout from Stanford University\, quickly grew to a global genetic testing company with >200 employees (acquired by Quest Diagnostics in 2020). With a solid background in pediatric cardiology and cardiovascular research\, Tero-Pekka recently joined CardioSignal by Precordior as the Chief Medicinal Officer and General Manager of the US operations. During his talk\, he will share his insights on how technology can revolutionize the medical methodology for a sustainable future and better use of resources. \n\n\n\nRegister to receive zoom link\n\n\n\n\n\n\n\nTero-Pekka Alastalo\, MD\, PhD\, is the Chief Medical Officer and General Manager of the US operations at CardioSignal by Precordior. He also co-founded Blueprint Genetics in 2012. Tero-Pekka obtained his MD\, PhD degree at the University of Turku in 2001. After 6 years of fellowships in pediatrics at the University of Turku\, he pursued his postdoctoral studies at Stanford University in basic research on cardiovascular biology and disease in the Marlene Rabinovitch Lab during 2007-2009. Upon returning to Finland\, he joined the University of Helsinki as a PI studying molecular and genetic mechanisms of cardiovascular diseases\, as well as a pediatric cardiology fellowship. In 2012 he joined forces with fellow Stanford postdoc Samuel Myllykangas to co-found Blueprint Genetics and held various management roles including Chief Medical Officer until September 2021\, when he joined CardioSignal. \n\n\n\nBlueprint Genetics is a genetic testing company focused on inherited diseases. With a patient-first mindset\, the company delivers high-quality genetic testing to the global clinical community (<4000 clinicians) across 15 medical specialties. Blueprint Genetics is based in Helsinki and Seattle\, with a customer base spanning over 70 countries. By combining a state-of-the-art laboratory process\, the latest sequencing technology\, AI empowered data-crunching tools and techniques\, world-class professionals\, and a holistic customer experience approach\, genetic knowledge is introduced to mainstream healthcare. Blueprint Genetics was acquired by Quest Diagnostics in 2020. \n\n\n\nCardioSignal by Precordior is a scientific forerunner in the field of cardiac motion sensing\, especially chest micro-rotation via micro-electromechanical sensors (MEMS) with some 30 scientific articles published in the area\, including in the prestigious journals Circulation and Nature Scientific Reports. The academic research studying the heart via chest micro-motions started at the University of Turku in January 2012. Continuing this work\, scientists at Precordior work today in close collaboration with researchers and cardiologists at several universities and hospitals. CardioSignal offers an easy and reliable detection of heart disease to people worldwide at an affordable price\, with an application that is accurate and reliable enough to serve physicians\, while easy and accessible enough to empower consumers. This is achieved via a smartphone application that transforms a phone into a device that can detect atrial fibrillation and\, in the future\, other heart conditions as well. \n\n\n\n\n\n\n\n\n\n“Clinical Talks” has been renewed for yet another exciting\, innovative\, and enlightening season. This season will focus on sustainable innovations within Life Sciences\, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations . \n\n\n\nSeason 5\, will be held September 2021 until March 2022 with scheduled Talks\, during Friday mornings 09-09:30 am via ZOOM (with some time-zone friendly adjustments for our international speakers). Each session consists of a talk given by our invited speaker followed by Q&A. The seminar is an open educational seminar series for our ever-expanding Life Science community.
URL:https://www.scilifelab.se/event/spearheading-the-cardiovascular-precision-medicine-with-innovative-medical-tools/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220224T132500
DTEND;TZID=Europe/Stockholm:20220225T150000
DTSTAMP:20260406T185347
CREATED:20220216T093937Z
LAST-MODIFIED:20220222T154735Z
UID:10000529-1645709100-1645801200@www.scilifelab.se
SUMMARY:DDLS Fellow positions at Stockholm University
DESCRIPTION:Welcome to attend the open\, on-line presentations given as part of the recruitment process for the two Tenure-Track positions as Assistant Professors in Data-Driven Cell and Molecular Biology at Stockholm University\, 24 February\, 13.25–15.20 och 25 February\, 13.25–15.00. \n\n\n\nFull program and zoom link HERE \n\n\n\n\n\n\n\n\n\n\n\nProgramme\n\n\n\nFebruary 24\n\n\n\n13.25–13.40    Jonathan Desponds Inference and prediction of transcription dynamics: application to the developmental pathways and the selection of T-cells \n\n\n\n13.45–14.00    Fabian Froehlich Mechanistic Models for Data-Driven Drug Sensitivity Prediction \n\n\n\n14.05–14.20    Juliette Griffie Characterising cellular processes at the nanoscale: beyond the pretty picture \n\n\n\n14.25–14.40    Jakub Wiktor Live cell microscopy reveals homology search mechanism  \n\n\n\n14.45–15.00    Michael Ratz Next-generation lineage tracing of brain development \n\n\n\n15.05–15.20    Severin SchinkTowards a quantitative understanding of ageing in cellular model systems \n\n\n\nFebruary 25\n\n\n\n13.25–13.40    Kimberly Siletti Molecular architecture of the mammalian brain    \n\n\n\n13.45–14.00    Linas Urnavicius Multidisciplinary study of molecular mechanisms governing cellular organization \n\n\n\n14.05–14.20    Axel OlinBlood-Based Assays for Human Systems Immunology \n\n\n\n14.25–14.40    Cheng ZhangSystems biology in liver disease \n\n\n\n14.45–15.00    Sofie Ährlund-Richter The ins and outs of the Prefrontal Cortex – Large-scale connectivity mapping and functional imaging of the Prefrontal Cortex \n\n\n\nChairing the presentations and the recruitment process is Professor Catarina Rydin. Acting as external reviewers for the recruitment are Professors Dagmar Iber\, Janet Thornton and Andreas Tolias. 
URL:https://www.scilifelab.se/event/ddls-fellow-position-at-stockholm-university/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2022/02/image-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220224T150000
DTEND;TZID=Europe/Stockholm:20220224T160000
DTSTAMP:20260406T185347
CREATED:20220210T162445Z
LAST-MODIFIED:20220215T171729Z
UID:10000525-1645714800-1645718400@www.scilifelab.se
SUMMARY:FAIRPoints Presents- Step by step publishing with ResearchEquals
DESCRIPTION:Chris Hartgerink\n\n\n\nSpeakers bio.  \n\n\n\nFAIRPoints is an event series highlighting pragmatic measures developed by the community towards the implementation of the FAIR (Findable\, Accessible\, Interoperable\, Reusable) data principles\, in collaboration with GoFAIR US\, SDSC\, AGU\, and SciLifeLab Data Centre.  \n\n\n\nIn this talk\, we will explore the open source publishing platform ResearchEquals\, where you can publish your entire research journey\, step by step. With this\, researchers get the autonomy to make all their research outputs findable\, accessible\, interoperable\, and reusable. In this presentation\, Chris Hartgerink shows how you can get started with this new publishing system and how you can help shape its future development.  \n\n\n\n\n\nSee Event in your Time Zone  \n\n\n\n\n\nLocation: Online via Zoom \n\n\n\n\n\n \n\n\n\n\n\n\n\nRegister Here\n\n\n\n\n\nSign up for future events here \n\n\n\n\n\n\nTweets by FAIR_Points
URL:https://www.scilifelab.se/event/fairpoints-researchequals/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Data Centre":MAILTO:datacentre@scilifelab.se
END:VEVENT
END:VCALENDAR